Farmaceutica is selling at 0.64 as of the 19th of March 2025; that is 1.59% increase since the beginning of the trading day. The stock's open price was 0.63. Farmaceutica has 50 percent odds of going through some form of financial distress in the next two years and did not have a very good performance for investor during the last 90 trading days. The performance scores are derived for the period starting the 19th of December 2024 and ending today, the 19th of March 2025. Click here to learn more.
Although Farmaceutica's alpha and beta are two of the key measurements used to evaluate Farmaceutica's performance over the market, the standard measures of volatility play an important role as well.
The output start index for this execution was zero with a total number of output elements of sixty-one. Farmaceutica R Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Farmaceutica price patterns.
Our tools can tell you how much better you can do entering a position in Farmaceutica without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Pattern Recognition Now
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Other Information on Investing in Farmaceutica Stock
Farmaceutica financial ratios help investors to determine whether Farmaceutica Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Farmaceutica with respect to the benefits of owning Farmaceutica security.